Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection

Chen Xi Yang,Michael Tomchaney,Manuel F. Landecho,Borja R. Zamacona,Marta Marin Oto,Javier Zulueta,Joshua Malo,Steve Knoper,Marco Contoli,Alberto Papi,Dragoş M. Vasilescu,Maor Sauler,Christof Straub,Cheryl Tan,Fernando D. Martinez,Deepta Bhattacharya,Ivan O. Rosas,Farrah Kheradmand,Tillie-Louise Hackett,Francesca Polverino

DOI: https://doi.org/10.3390/cells11121864

IF: 6

2022-06-08

Cells

Abstract:People with pre-existing lung diseases such as chronic obstructive pulmonary disease (COPD) are more likely to get very sick from SARS-CoV-2 disease 2019 (COVID-19). Still, an interrogation of the immune response to COVID-19 infection, spatially throughout the lung structure, is lacking in patients with COPD. For this study, we characterized the immune microenvironment of the lung parenchyma, airways, and vessels of never- and ever-smokers with or without COPD, all of whom died of COVID-19, using spatial transcriptomic and proteomic profiling. The parenchyma, airways, and vessels of COPD patients, compared to control lungs had (1) significant enrichment for lung-resident CD45RO+ memory CD4+ T cells; (2) downregulation of genes associated with T cell antigen priming and memory T cell differentiation; and (3) higher expression of proteins associated with SARS-CoV-2 entry and primary receptor ubiquitously across the ROIs and in particular the lung parenchyma, despite similar SARS-CoV-2 structural gene expression levels. In conclusion, the lung parenchyma, airways, and vessels of COPD patients have increased T-lymphocytes with a blunted memory CD4 T cell response and a more invasive SARS-CoV-2 infection pattern and may underlie the higher death toll observed with COVID-19.

cell biology